Healixia is the result of a convergence between ACRP.be, BAPU, BeAPP and BRAS which will continue as a joint new member association.Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy. Healixia provides development, education, training and networking opportunities across all members and disciplines. Healixia aims to further professionalize its members and concerned disciplines and is open to work with all relevant stakeholders towards a strong community of professionals in Belgium.

It's a pleasure working together!infarAMA bvba offers services for Regulatory Affairs, Quality, Vigilance, Information & Publicity and Translations from small local to world-wide leading health care companies for medicinal products, medical devices and food supplements.Our mission is to take care of your technical, scientific and administrative projects when you are in need of a partnership with an experienced team. Our know-how, based on more than twenty years of experience, guarantees an accurate realisation of your projects.It’s a pleasure working together!Noëlla Heyman and Marian Coquel (co-founders)+32 11 31 26 16 – office@infarama.beFor more details, please visit our website www.infarama.be.

A company offering a unique blend of services in Healthcare Business Consulting. In Step-Wiser 4 companies (infarAMA, Prospex, e&a pharma and Smart & Bi) have teamed up to offer a one-stop-shop for healthcare organizations wishing to establish themselves in Belgium or in Europe, to expand their existing business and to revitalize their organization and projects.

BRAS is a professional organisation of people involved in regulatory affairs that supports its members to achieve the highest standards through information and training, and participates on an active and constructive way to the policymaking within the pharmaceutical and related sectors.